Oral Chinese medicinal preparation for treating vascular dementia

A technology for vascular dementia and traditional Chinese medicine, which is applied in the field of oral traditional Chinese medicine preparations for the treatment of vascular dementia, can solve the problems of slow onset, high cost, poor efficacy and the like

Active Publication Date: 2005-08-24
SHANGHAI PHARMA GRP QINGDAO GROWFUL PHARMA CO LTD
View PDF0 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] With the deepening of clinical and experimental research on encephalopathy in traditional Chinese medicine, many traditional Chinese medicines and traditional Chinese medicine compound prescriptions have been found to have certain effects on the pre

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017] The following examples further illustrate the beneficial effects of the drug of the present invention.

[0018] Preparation process: According to the above prescription range, prepare the raw materials of Polygonum multiflorum 550g, Astragalus 825g, Angelica 275g, Chuanxiong 275g, Ligustrum lucidum 275g, Cynomorium 220g, Pueraria 165g, Polygala 165g, Shichangpu 110g. The Ligustrum lucidum is crushed, the Polygonum multiflorum is crushed into granules, and the astragalus and puerariae are refluxed with ethanol for two times, and the ethanol is recovered under reduced pressure and concentrated to a clear paste. The volatile oils of Acorus calamus, Angelica and Chuanxiong were extracted by steam distillation. The volatile oils were wrapped with β-cyclodextrin, and part of the water extract was kept for use. Polygala and Cynomorium were boiled and extracted three times. The boiled liquid is combined with the water extract of Shichangpu, Angelica and Chuanxiong, concentrated, co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An orally taken Chinese medicine for treating vascular dementia is prepared from fleece flower root, astragalus root, Chinese angelica root, Chuan-xiong rhizome and lucid ligustrum fruit.

Description

Technical field [0001] The invention belongs to the technical field of traditional Chinese medicine, and specifically relates to a traditional Chinese medicine oral preparation for treating vascular dementia. Background technique [0002] Senile vascular dementia is a common disease in the process of human aging. It is a syndrome of advanced brain hypofunction. It is one of the modern intractable diseases listed by the World Health Organization. There is no ideal and effective treatment at present. According to the World Health Organization survey, the prevalence of senile dementia over 65 years old accounts for 4-5%, of which vascular dementia after cerebrovascular disease accounts for about 1 / 3-2 / 3 of senile dementia, and in vascular dementia More than 90% are multiple infarct dementia. With the changes in the spectrum of human diseases and the prolongation of human life spans and my country is another area with a high incidence of stroke, the prevalence ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61P25/28
Inventor 张庭广
Owner SHANGHAI PHARMA GRP QINGDAO GROWFUL PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products